|
YWHAB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.248800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.359400E-01 |
| Normal-vs-Stage2 |
4.324200E-01 |
| Normal-vs-Stage3 |
4.526000E-02 |
| Normal-vs-Stage4 |
1.099570E-01 |
| Stage1-vs-Stage2 |
5.133600E-01 |
| Stage1-vs-Stage3 |
5.279800E-02 |
| Stage1-vs-Stage4 |
1.205220E-01 |
| Stage2-vs-Stage3 |
4.956000E-01 |
| Stage2-vs-Stage4 |
5.239600E-01 |
| Stage3-vs-Stage4 |
9.226800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.982400E-01 |
| Normal-vs-AfricanAmerican |
2.313600E-01 |
| Normal-vs-Asian |
9.079000E-01 |
| Caucasian-vs-AfricanAmerican |
6.581200E-01 |
| Caucasian-vs-Asian |
4.129400E-01 |
| AfricanAmerican-vs-Asian |
3.316200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.267600E-02 |
| Normal-vs-Female |
4.893400E-01 |
| Male-vs-Female |
8.703600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.938600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.714050E-01 |
| Normal-vs-Age(61-80Yrs) |
2.014100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.300000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.494360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.558320E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.974000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.298400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.166200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.311800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.833000E-01 |
| Classical-VS-Follicular |
2.939700E-03 |
| Classical-VS-Other |
7.440100E-02 |
| Classical-VS-Normal |
9.200600E-01 |
| Tall-VS-Follicular |
3.515600E-01 |
| Tall-VS-Other |
2.100600E-01 |
| Tall-VS-Normal |
3.900400E-01 |
| Follicular-VS-Other |
5.148400E-01 |
| Follicular-VS-Normal |
2.155600E-02 |
| Other-VS-Normal |
2.059400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.034410E-01 |
| Normal-vs-N1 |
7.492200E-02 |
| N0-vs-N1 |
4.970600E-01 |
|
|
